Shopping Cart
- Remove All
Your shopping cart is currently empty
13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2. It inhibits the ADP-induced aggregation of human platelets with an ED50 of about 40 nM in PRP and 77 nM in washed platelets, which is comparable to the potency of carbaprostacyclin.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 50 μg | $223 | 35 days | |
| 100 μg | $417 | 35 days | |
| 500 μg | $1,720 | 35 days |
| Description | 13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2. It inhibits the ADP-induced aggregation of human platelets with an ED50 of about 40 nM in PRP and 77 nM in washed platelets, which is comparable to the potency of carbaprostacyclin. |
| Molecular Weight | 346.467 |
| Formula | C21H30O4 |
| Cas No. | 145375-81-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMF: >10 mg/mL (from 6B-PGI2), Sonication is recommended. DMSO: >5 mg/mL (from 6B-PGI2), Sonication is recommended. PBS (pH 7.2): >80 mg/mL (from 6B-PGI2), Sonication is recommended. Ethanol: >20 mg/mL (from 6B-PGI2), Sonication is recommended. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.